Evaluation of Visual Outcomes, Complications, and Neuroadaptation Following Bilateral Implantation of enVista Envy Trifocal Intraocular Lenses
The enVista Envy intraocular lens (IOL) manufactured by Bausch + Lomb is a new multifocal intraocular lens based on diffractive optics. It was registered with the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in September 2025. The lens also bears the CE mark, indicating that it is approved for marketing and use within the European Union.
Its innovative design is based on a smooth, continuous transition between diffractive rings, allowing patients to achieve excellent visual quality at far, intermediate, and near distances while reducing the incidence and severity of unwanted photic phenomena such as glare and halos. Thanks to this technology, patients may achieve better uncorrected visual acuity, reduced dependence on spectacles, and faster neuroadaptation.
The Second Department of Ophthalmology is the first center in Poland to be offered participation in a clinical study evaluating the safety and effectiveness of the enVista Envy IOL. The planned study will provide the first clinical experience with this lens in Poland and contribute to expanding knowledge regarding modern intraocular lens technologies.
Twenty patients will be selected according to predefined inclusion and exclusion criteria. Preoperative assessment will include a comprehensive ophthalmic examination and IOL power calculation. Cataract surgery will be performed using bimanual MICS (Micro-Incision Cataract Surgery) phacoemulsification. Surgery in the fellow eye will be performed one month after the first procedure.
Before surgery and during follow-up visits at 1, 3, and 6 months postoperatively, the following assessments will be performed: routine ophthalmic examination, intraocular pressure (IOP) measurement, visual evoked potentials (VEP), monocular and binocular uncorrected distance visual acuity (UDVA), distance best-corrected visual acuity (DBCVA) at 4 meters, intermediate visual acuity (66 cm) and near visual acuity (40 cm), both corrected and uncorrected, monocularly and binocularly (logMAR charts), binocular contrast sensitivity testing, and defocus curve assessment.
Intraoperative and postoperative complications, quality of vision (using the standardized Quality of Vision Questionnaire [QoV] and the Near Activity Vision Questionnaire [NAVQ]), speed of neuroadaptation, spectacle independence, and the occurrence of photic phenomena such as glare and halos will also be analyzed.
Panoramica dello studio
Stato
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Wojciech Lubiński
- Numero di telefono: +48 91 466 12 93
- Email: oko@pum.edu.pl
Backup dei contatti dello studio
- Nome: Zuzanna Warenik
- Numero di telefono: +48 91 466 12 93
- Email: z.warenik@usk2.szczecin.pl
Luoghi di studio
-
-
Zachodnipomorskie
-
Szczecin, Zachodnipomorskie, Polonia, 70-111
- Reclutamento
- II Department of Ophthalmology, Pomeranian Medical University
-
Contatto:
- Wojciech Lubiński
- Numero di telefono: +48 91466 12 93
- Email: oko@pum.edu.pl
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Bilateral cataract or refractive lens exchange candidates.
- Presbyopia and/or hyperopia.
- Preoperative corneal astigmatism less than 1.00 diopter (D).
- Absence of ocular diseases other than cataract.
- High motivation to achieve spectacle independence.
- Patients willing to accept the possibility of mild photic phenomena, such as glare and halos.
Exclusion Criteria:
Ocular Conditions:
- Glaucoma.
- Amblyopia.
- Macular diseases (including macular degeneration and other macular pathology).
- Angle kappa greater than 0.5 mm.
- Dry eye disease.
- Corneal disorders.
- Pupil abnormalities.
- Irregular astigmatism.
- Ocular motility disorders or strabismus.
- Pupil diameter < 2.5 mm under photopic conditions or > 6.0 mm under mesopic conditions.
- Abnormalities of the capsular bag or zonular apparatus, including pseudoexfoliation syndrome (PEX).
Lifestyle Factors:
- Patients with unrealistic expectations regarding postoperative visual outcomes.
- Individuals whose professions require highly precise visual performance, such as pilots, professional drivers, architects, or similar occupations.
- Patients satisfied with using spectacles for near vision.
- Age greater than 75 years (due to potential difficulties with neuroadaptation to new visual conditions).
Psychological and Personality Factors:
- Patients with psychiatric disorders that may interfere with study participation or outcome assessment.
- Patients dissatisfied with progressive addition lenses (progressive spectacles).
- Patients with dyslexia or a history of stroke.
- Type A personality traits (perfectionists).
- Patients will also be excluded if the calculated IOL power falls outside the available range of +6.00 D to +34.00 D or if they have a history of laser vision correction surgery.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: 20 patients (40 eyes)
Patients who meet all inclusion criteria and none of the exclusion criteria.
|
Surgery performed using the NGENUITY® 3D Visualization System.
Two-handed Micro-Incision Cataract Surgery (MICS) technique.
Corneal incisions measuring 1.2 × 1.4 mm at the 2 o'clock and 10 o'clock positions.
Continuous curvilinear capsulorhexis with a diameter of approximately 5 mm.
Ultrasound phacoemulsification.
Intraocular lens (IOL) implantation through a 2.2-2.3 mm incision.
The implanted intraocular lens (IOL) will be the enVista Envy IOL.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Visual function at distance, intermediate, and near ranges.
Lasso di tempo: Preoperatively and at 1, 3, and 6 months postoperatively.
|
Improvement in visual function at distance (4 m), intermediate (66 cm), and near (40 cm) distances following bilateral implantation of the enVista Envy IOL.
|
Preoperatively and at 1, 3, and 6 months postoperatively.
|
|
Neuroadaptation time.
Lasso di tempo: From surgery to 6 months postoperatively.
|
Reduction in the time required for neuroadaptation following bilateral implantation of the enVista Envy IOL.
|
From surgery to 6 months postoperatively.
|
|
Intraoperative and postoperative complications.
Lasso di tempo: From surgery to 6 months postoperatively.
|
Assessment of adverse events and complications associated with cataract surgery and implantation of the enVista Envy IOL.
|
From surgery to 6 months postoperatively.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Binocular contrast sensitivity.
Lasso di tempo: Preoperatively and at 1, 3, and 6 months postoperatively.
|
Assessment of binocular contrast sensitivity under photopic and mesopic conditions.
|
Preoperatively and at 1, 3, and 6 months postoperatively.
|
|
Quality of vision and Near vision-related quality of life assessed using Questionnaires
Lasso di tempo: At 1, 3, and 6 months postoperatively.
|
Evaluation of subjective visual quality, including frequency, severity, and bothersomeness of visual disturbances - Quality of Vision (QoV) Questionnaire.
Evaluation of patient-reported ability to perform near-vision activities and overall satisfaction with near vision - The Near Activity Visual Questionnaire (NAVQ).
|
At 1, 3, and 6 months postoperatively.
|
|
Incidence and severity of photic phenomena.
Lasso di tempo: At 1, 3, and 6 months postoperatively.
|
Assessment of the occurrence and severity of photic phenomena reported by participants.
|
At 1, 3, and 6 months postoperatively.
|
|
Spectacle independence.
Lasso di tempo: At 1, 3, and 6 months postoperatively.
|
Assessment of participants' need for spectacles for distance, intermediate, and near vision tasks.
|
At 1, 3, and 6 months postoperatively.
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- enVista Envy
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .